Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -3.96% | 58.19 | 0.0% | $1899.37m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.26% | 597.00 | 2.5% | $1174.48m | |
| GILD | Gilead Sciences, Inc. | -1.02% | 76.75 | 1.0% | $975.82m | |
| AMGN | Amgen, Inc. | 2.17% | 225.67 | 1.3% | $660.44m | |
| NVAX | Novavax, Inc. | 3.67% | 46.30 | 102.0% | $655.72m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -2.61% | 265.69 | 1.9% | $544.78m | |
| ILMN | Illumina, Inc. | -1.20% | 354.11 | 3.5% | $388.06m | |
| BIIB | Biogen, Inc. | 2.36% | 306.72 | 1.6% | $378.26m | |
| SRNE | Sorrento Therapeutics, Inc. | 6.74% | 4.12 | 1.8% | $269.11m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.35% | 115.21 | 2.0% | $241.70m | |
| SGEN | Seattle Genetics, Inc. | -1.36% | 148.39 | 6.1% | $223.95m | |
| A | Agilent Technologies, Inc. | -0.83% | 90.38 | 1.6% | $215.81m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -1.59% | 105.80 | 4.3% | $184.97m | |
| SRPT | Sarepta Therapeutics, Inc. | 2.06% | 147.99 | 13.9% | $156.63m | |
| INCY | Incyte Corp. | -0.31% | 93.51 | 2.5% | $153.41m |
Company Profile
Soligenix, Inc. is a late-stage biopharmaceutical company, which engages in the development and commercialization of products to treat rare disease. It operates through Specialized BioTherapeutics and Public Health Solutions segments. The Specialized BioTherapeutics segment focuses in the development of a novel photodynamic therapy (SGX301) utilizing topical synthetic hypericin activated with safe visible fluorescent light for the treatment of cutaneous T-cell lymphoma. The Public Health Solutions solutions comprises active development programs for RiVax, ricin toxin vaccine candidate and SGX943, a therapeutic candidate for antibiotic resistant and emerging infectious disease. The company was founded in 1987 and is headquartered Princeton, NJ.